What antibiotics are used to treat Aerococcus infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Aerococcus Infections

Penicillin is the first-line antibiotic treatment for Aerococcus infections, with combination therapy including an aminoglycoside recommended for serious infections such as endocarditis or bacteremia. For less severe infections like uncomplicated urinary tract infections, ampicillin or nitrofurantoin are appropriate options.

First-Line Treatment Options

Invasive Aerococcus Infections

  • Penicillin or ampicillin is the cornerstone of treatment for invasive Aerococcus infections 1, 2
  • For serious infections (endocarditis, bacteremia):
    • Combine penicillin with an aminoglycoside for synergistic effect 2, 3
    • This combination is particularly important for Aerococcus urinae endocarditis

Urinary Tract Infections

  • Ampicillin is considered a safe treatment option for complicated UTIs 3
  • Nitrofurantoin is effective for uncomplicated UTIs 3, 4
  • Recent studies show 100% susceptibility of Aerococcus species to nitrofurantoin 4

Alternative Treatment Options

When penicillins cannot be used, the following alternatives are appropriate:

  • Vancomycin: 100% susceptibility reported in recent studies 4
  • Carbapenems (e.g., meropenem): Highly effective against Aerococcus species 3, 4

Antibiotics to Avoid

  • Fluoroquinolones: Approximately 10.9% of Aerococcus isolates show resistance to ciprofloxacin 4
  • Trimethoprim-sulfamethoxazole: A. urinae is resistant to sulfamethoxazole, and there are methodological problems in determining trimethoprim sensitivity 3

Species-Specific Considerations

Aerococcus urinae

  • Highly susceptible to penicillins, carbapenems, vancomycin, and nitrofurantoin 4
  • Nitroxoline shows promising activity (97.6% susceptibility) and could be an alternative for UTIs, though clinical studies are needed 4

Aerococcus sanguinicola

  • Similar susceptibility pattern to A. urinae for most antibiotics
  • Not susceptible to nitroxoline (should be considered intrinsically resistant) 4

Treatment Duration and Monitoring

  • For uncomplicated UTIs: Standard short-course therapy (typically 3-5 days)
  • For invasive infections: Extended therapy (2-4 weeks for bacteremia; 4-6 weeks for endocarditis)
  • Close monitoring of clinical status and laboratory results is essential, especially for serious infections 2

Clinical Pearls

  • Aerococci are gram-positive cocci often misidentified as streptococci or staphylococci 1
  • Aerococcus infections are more common in elderly patients with urinary tract abnormalities or indwelling catheters 5
  • Prompt and culture-specific treatment is critical to avoid clinical progression of the infection 5
  • Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) has improved accurate identification of Aerococcus species 1

The treatment of Aerococcus infections should be guided by antimicrobial susceptibility testing whenever possible, as patterns of resistance may vary regionally.

References

Research

Aerococci and aerococcal infections.

The Journal of infection, 2013

Research

Three cases of serious infection caused by Aerococcus urinae.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1999

Research

Aerococcus: an increasingly acknowledged human pathogen.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.